Skip to main content

MoneyWorks4Me

Himalaya Nutravedics India informs about statement of deviation or variation

12 Nov 2026 Evaluate

Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Himalaya Nutravedics India has informed that it attached the Statement of Deviation(s) or Variation(s) for the half year ended 30t September, 2026, duly reviewed and approved by the Audit Committee and Board of Directors of the Company at its meeting held on 12th November, 2026. The company has informed that there has been no any deviation(s) or Variation(s) in the use of proceeds as stated in the objects of the Equity issue in the offer document/ prospectus.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1870.30
Dr. Reddys Labs. 1383.30
Cipla 1389.95
Lupin 1951.80
Zydus Lifesciences 1202.70
View more..